FDA yanks EUA for AstraZeneca’s Evusheld as COVID variants continue to evolve

FDA yanks EUA for AstraZeneca’s Evusheld as COVID variants continue to evolve

Source: 
Medical Marketing and Media
snippet: 

AstraZeneca said it will continue to work with the FDA and other health authorities to “collect, assess and share relevant data” regarding Evusheld and COVID-19 variants.